118 related articles for article (PubMed ID: 17394284)
1. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.
Mandal-Ghosh I; Chattopadhyay U; Baral R
Cancer Immun; 2007 Mar; 7():8. PubMed ID: 17394284
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.
Baral R; Mandal I; Chattopadhyay U
Int Immunopharmacol; 2005 Jul; 5(7-8):1343-52. PubMed ID: 15914339
[TBL] [Abstract][Full Text] [Related]
3. Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 mice by activation of NK cells and NK-T cells.
Haque E; Baral R
Immunobiology; 2006; 211(9):721-31. PubMed ID: 17015147
[TBL] [Abstract][Full Text] [Related]
4. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
5. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
[TBL] [Abstract][Full Text] [Related]
6. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
Baral R; Chattopadhyay U
Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
[TBL] [Abstract][Full Text] [Related]
7. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
8. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
9. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
[TBL] [Abstract][Full Text] [Related]
10. Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice.
Siveen KS; Kuttan G
J Immunotoxicol; 2012; 9(1):25-33. PubMed ID: 22129065
[TBL] [Abstract][Full Text] [Related]
11. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen.
Sarkar K; Bose A; Laskar S; Choudhuri SK; Dey S; Roychowdhury PK; Baral R
Int Immunopharmacol; 2007 Mar; 7(3):306-12. PubMed ID: 17276888
[TBL] [Abstract][Full Text] [Related]
12. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
13. Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.
Chu Y; Xia M; Lin Y; Li A; Wang Y; Liu R; Xiong S
Cancer Gene Ther; 2006 May; 13(5):510-9. PubMed ID: 16341143
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
Hamsa TP; Kuttan G
Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
[TBL] [Abstract][Full Text] [Related]
16. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
Gao D; Kasten-Jolly J; Lawrence DA
Toxicol Sci; 2006 Feb; 89(2):444-53. PubMed ID: 16280381
[TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
19. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
[TBL] [Abstract][Full Text] [Related]
20. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
Kim TY; Myoung HJ; Kim JH; Moon IS; Kim TG; Ahn WS; Sin JI
Cancer Res; 2002 Dec; 62(24):7234-40. PubMed ID: 12499264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]